Who Should Be on Your Rare Disease Care Team?

team of doctors and nurses

Living with a rare disease often means working with more than one healthcare provider. For individuals and families affected by Generalized Arterial Calcification of Infancy (GACI), ARHR2, ENPP1 Deficiency, ABCC6 Deficiency, and related conditions, care can involve several medical specialties because these conditions may affect different parts of the body throughout a person’s life.

GACI primarily affects the circulatory system and can involve other organs, while ENPP1 Deficiency may also affect bones, joints, hearing, eyes, teeth, growth, and mobility. ABCC6 Deficiency can affect the vascular system as well as the eyes and skin. ARHR2 is particularly associated with phosphate loss, rickets, bone, joint, and muscle pain, skeletal changes, and other complications.

That means there is rarely a single doctor who manages every aspect of care.

However, not every patient will need every specialist listed below. Your care team should be based on your diagnosis, age, symptoms, medical history, current treatment, and individual needs.

Rare Disease Care Looks Different Around the World

Brighter Hope Foundation supports families around the world, and access to rare disease specialists can vary significantly depending on where you live.

In pediatric care, families often receive comprehensive, coordinated support through a children’s hospital, metabolic bone center, or dedicated rare disease clinic. However, as patients transition into adult healthcare systems, care frequently becomes less centralized, and the benefit of a single multi-disciplinary team may no longer be available. Adults may need to build their own network of individual specialists – such as endocrinologists, cardiologists, or nephrologists – working alongside a primary care physician or general practitioner.

Regardless of age, some patients may need to travel significant distances for specialized appointments, while others can utilize telemedicine to consult with experts experienced in their condition. Referral processes, medical specialty names, healthcare coverage, and provider availability also differ between the United States, European countries, and other global regions.

The goal is therefore not necessarily to have every specialist in the same hospital or even the same city. What matters is having access to the appropriate expertise and, whenever possible, good communication between the providers involved in your care.

Brighter Hope’s FAQ and Glossary also provides information for families looking for doctors or hospitals with experience treating GACI and ARHR2.

Who Might Be Part of Your Rare Disease Care Team?

Depending on the patient’s needs, a care team for GACI, ARHR2, ENPP1 Deficiency, or ABCC6 Deficiency may include several types of healthcare professionals.

Primary Care Provider or Pediatrician

A primary care provider, general practitioner, or pediatrician can serve as an important central point in a complex care team.

While rare disease specialists may manage condition-specific concerns, primary care providers continue to oversee everyday health needs, including routine examinations, vaccinations, common illnesses, developmental concerns, and general wellness.

They may also help coordinate referrals, maintain an updated medical history, monitor changes in overall health, communicate with specialists, and help patients or caregivers  decide when a new symptom may require additional evaluation.

For patients  seeing specialists at multiple hospitals or medical centers, having a local provider who understands the overall picture can be particularly valuable.

Geneticist and Genetic Counselor

GACI and related conditions have known genetic causes, making clinical genetics an important part of care for many patients.

GACI Type 1 and ARHR2 are associated with mutations in the ENPP1 gene, while GACI Type 2 is associated with mutations in the ABCC6 gene. Brighter Hope’s Genetics & Inheritance resource explains these relationships in greater detail and provides information about inheritance patterns and genetic testing.

A medical geneticist or genetic counselor can help patients or caregivers understand genetic test results, discuss how a condition is inherited, determine whether testing may be appropriate for other family members, and talk through what a genetic diagnosis could mean for future family planning.

Because knowledge about rare genetic diseases continues to evolve, patients may also benefit from revisiting their genetic information over time.

Cardiologist

While early cardiology care can be critical for babies and children diagnosed with GACI, ongoing cardiovascular monitoring remains essential throughout adulthood.

GACI is characterized by abnormal calcification and narrowing of medium- and large-sized arteries. This can restrict blood flow and place significant strain on the cardiovascular system.

A cardiologist may monitor heart function, blood pressure, circulation, and changes in the arteries through physical examinations, cardiac imaging, and other testing determined by the patient’s medical team.

The type and frequency of cardiovascular monitoring will depend on the individual’s diagnosis, age, symptoms, and medical history. Families can also learn more about approaches to managing cardiovascular and other complications on Brighter Hope’s Treatment Options page.

Nephrologist

A nephrologist specializes in kidney health, and kidney monitoring can be an important part of care for some individuals with GACI, ENPP1 Deficiency, and ARHR2.

For patients with ARHR2, one concern is nephrocalcinosis, or calcium deposits within the kidneys. Kidney monitoring may be especially important for patients receiving phosphate supplementation as part of their treatment.

A nephrologist may monitor kidney function, calcium and phosphate balance, calcium levels in the urine, nephrocalcinosis, and other kidney-related complications.

For patients being treated for ARHR2, communication between nephrology and endocrinology can be especially important as providers work to support both bone and kidney health. For more information on terms such as nephrology or nephrocalcinosis, you can find additional explanations in Brighter Hope Foundation’s FAQ and Glossary of Terms.

Endocrinologist or Metabolic Bone Specialist

An endocrinologist—particularly one with experience in metabolic bone disorders—may play a major role in caring for individuals with ARHR2 and ENPP1 Deficiency.

ARHR2 causes the kidneys to lose too much phosphate, resulting in low phosphate levels in the blood. Because phosphate is essential for healthy bone mineralization, this can contribute to rickets, bone deformities, pain, fractures, growth concerns, and other skeletal complications.

An endocrinologist or metabolic bone specialist may monitor phosphate and mineral metabolism, bone health, growth, laboratory results, rickets or osteomalacia, and medications or supplements used as part of treatment.

Because treatment needs can change as a child grows or as an adult’s condition changes, continued follow-up may be important.

Audiologist

Hearing should not be overlooked when building a rare disease care team.

Hearing loss can occur in people with ENPP1 Deficiency and GACI, and may be present from birth or develop later.

An audiologist can evaluate hearing and monitor changes over time. If hearing loss is identified, audiologists and other hearing specialists can help determine appropriate interventions, devices, or accommodations.

For children, identifying hearing difficulties early may also support speech development, communication, learning, and participation at school.

Ophthalmologist

Some patients with ENPP1 Deficiency or ABCC6 Deficiency may develop eye-related complications.

For example, ABCC6 Deficiency may present later in life as pseudoxanthoma elasticum (PXE), which can affect the eyes as well as the skin and vascular system.

An ophthalmologist can examine structures within the eye, monitor for changes, and determine whether treatment or additional follow-up is necessary.

The need for ophthalmology care and the frequency of examinations will vary depending on an individual’s diagnosis, age, symptoms, and medical history.

Dentist and Dental Specialists

Dental care can also be an important—and sometimes overlooked—part of rare disease management.

People affected by GACI, ENPP1 Deficiency, and ARHR2 may experience dental abnormalities such as over-retained primary teeth, infraocclusion, ankylosis, slow orthodontic movement, and changes involving the roots of the teeth.

Regular dental care may help identify concerns early.

Depending on the patient’s needs, care could involve a general dentist, pediatric dentist, orthodontist, or another dental specialist. It can also be helpful for families to make sure their dental provider understands the patient’s rare disease diagnosis and relevant medical history before beginning significant dental or orthodontic treatment.

Additional definitions of dental and other condition-related terminology can be found in Brighter Hope Foundation’s Glossary of Terms.

Rehabilitation Specialists

Rare disease care is not only about laboratory results and medical imaging. It is also about helping patients move, participate in everyday activities, manage symptoms, and maintain as much independence as possible.

People with ARHR2 and ENPP1 Deficiency may experience bone and joint pain, skeletal deformities, muscle weakness, calcific enthesopathy, stiffness, fatigue, or reduced mobility. Brighter Hope Foundation’s article on living with chronic pain and fatigue in GACI and ARHR2 discusses some of the ways these symptoms can affect daily life.

Depending on the person’s needs, rehabilitation care may involve physical therapy, occupational therapy, physical medicine and rehabilitation, orthopedic care, or specialists in mobility and assistive equipment.

Rehabilitation may focus on strength, flexibility, mobility, daily activities, adapting the home, school, or work environment, recovery following surgery, or finding safe ways to participate in activities despite pain or fatigue.

Because some patients also have bone, joint, or cardiovascular complications, exercise and therapy plans should be individualized in collaboration with the patient’s medical team.

Your Care Team May Change Over Time

One of the challenges of managing a lifelong rare condition is that the specialists you need today may not be the same specialists you need several years from now.

An infant with GACI may initially require especially close cardiovascular monitoring. A child with ENPP1 Deficiency may later require greater attention to phosphate levels, growth, bone health, hearing, dental development, and mobility as manifestations of the condition change with age.

Similarly, adults may experience different bone, joint, mobility, vascular, eye, or other health concerns.

That is why rare disease care is often best thought of as an evolving team rather than a fixed list of doctors.

Families may also want to become familiar with Brighter Hope Foundation’s broader Treatment Options resources so they can stay informed about developments in care and research.

Helping Your Specialists Work as a Team

When several providers are involved, coordination becomes especially important.

Patients and caregivers may find it helpful to keep an updated medical summary containing diagnoses, medications, test results, surgeries, specialists, imaging reports, allergies, and important contact information.

Questions to discuss with your healthcare team may include:

  • Who is the main provider coordinating my or my child’s care?
  • Which specialists should we see regularly?
  • How often should monitoring or testing take place?
  • Which symptoms should prompt us to contact a specialist sooner?
  • Are our specialists sharing results and treatment plans with one another?
  • If an experienced specialist is not available locally, is a remote consultation possible?
  • Are there rare disease centers or specialists elsewhere in our country or region who could collaborate with our local doctors?

For rare and complex conditions, it is reasonable to ask healthcare providers to communicate with one another and clarify who is responsible for different aspects of care.

You Do Not Have to Navigate Rare Disease Care Alone

Finding healthcare professionals who understand an extremely rare condition can be challenging, particularly when local doctors have never previously treated someone with GACI, ARHR2, ENPP1 Deficiency, or ABCC6 Deficiency.

Brighter Hope Foundation works to connect affected families with one another and with the medical community while providing educational information and resources. The Foundation’s Medical Advisory Board includes medical professionals and researchers with expertise related to GACI, ARHR2, ENPP1 Deficiency, and ABCC6 Deficiency,.

Families can also explore Brighter Hope Foundation’s Fact Sheets and Leaflets, which include resources in multiple languages, or connect with other affected individuals through the Patient & Family Support Group.

Every patient’s care team will look a little different. The important thing is finding the right combination of expertise for the individual—and making sure the people involved understand not only one symptom or organ system, but the bigger picture of living with a rare, complex condition.

This information is intended for educational purposes and should not replace individualized medical advice. Patients and families should work with their healthcare providers to determine which specialists, testing, treatments, and monitoring are appropriate for their specific diagnosis and medical needs.

Back to School with GACI, ARHR2 and Related Rare Conditions

Student with a backpack walking through a classroom at the start of the school year

The start of a new school year brings new teachers, schedules, activities and routines. For families affected by Generalized Arterial Calcification of Infancy (GACI), Autosomal Recessive Hypophosphatemic Rickets Type 2 (ARHR2), ENPP1 Deficiency, ABCC6 Deficiency and related rare conditions, it can also mean making sure a child’s medical and accessibility needs are understood before the first day.

Children living with these conditions can have very different experiences. Some may experience bone or joint pain, fatigue or mobility challenges, while others may have hearing loss, skeletal differences or ongoing medication and medical monitoring needs. Learn more about GACI and ARHR2.

Preparing ahead and creating an open line of communication between families, teachers, school staff and healthcare providers can help students safely participate in school while receiving the support they need.

Consider an IEP or 504 Plan

classroom with backpacks hanging on chairs with papers on desk

For families in the United States, an Individualized Education Program (IEP) or Section 504 Plan may provide formal support for students whose medical condition affects their education or ability to participate fully in school.

An IEP is available to eligible students who require special education and related services, while a 504 Plan can provide accommodations that help students with disabilities access school and participate alongside their peers.

Depending on the individual student, accommodations could address:

  • Physical education and activity limitations
  • Extra rest or movement breaks
  • Mobility assistance
  • Additional time to move between classrooms
  • Elevator access
  • Accessible seating
  • Hearing accommodations
  • Modified attendance expectations for medical appointments
  • Access to medication during the school day
  • Frequent or extended bathroom breaks
  • Additional time for assignments following absences or periods of illness

Families outside the United States can ask their school what equivalent disability, medical or learning-support plans are available in their country.

Plan Ahead for PE and Physical Activity

Physical activity is an important part of the school day, but students with GACI, ARHR2, ENPP1 Deficiency or ABCC6 Deficiency may experience bone pain, muscle weakness, fatigue, skeletal abnormalities, joint calcification or reduced mobility.

Rather than automatically excluding a child from physical education, families can work with their medical team and school to determine what level and type of activity is appropriate.

Depending on medical recommendations, modifications might include:

  • Lower-impact activities
  • Additional rest periods
  • Shorter participation times
  • Avoiding certain high-impact exercises
  • Alternative activities when pain or fatigue increases
  • Allowing the student to stop or modify an activity when symptoms develop

The goal should be safe participation based on the individual child, not a one-size-fits-all restriction.

For more information about symptoms that can affect activity, read Living With Chronic Pain and Fatigue in GACI, ARHR2 and Related Conditions.

Put Hearing Accommodations in Place

students-with-raised-hands-in-classroom

Hearing loss can occur in people affected by ENPP1 Deficiency and related conditions and may be present from birth or develop progressively over time.

For a student with hearing loss, families may want to discuss classroom accommodations recommended by the child’s audiologist, healthcare provider or educational team, such as:

  • Preferential classroom seating
  • Reducing background noise when possible
  • Having teachers face the student while speaking
  • Captioning videos and digital materials
  • Written copies of important verbal instructions
  • Assistive listening technology when appropriate
  • Making sure substitute teachers understand the student’s needs
  • Checking that the student heard and understood assignments rather than assuming they did

The right support will depend on the type and severity of hearing loss and the individual student’s communication preferences and needs.

Learn more in our guide to Living with Progressive Hearing Loss.

Think About Mobility Throughout the Entire School Day

Mobility needs are not limited to gym class.

ARHR2 can cause skeletal abnormalities such as bowed legs or knock knees, while ENPP1 Deficiency and related conditions may be associated with joint calcification, bone and joint pain, muscle weakness and decreased mobility.

Families may want to walk through a typical school day and consider potential challenges. Is there enough time to get between classrooms? Are stairs required? Does the student need an elevator pass? Is their desk comfortable and accessible? How far is the classroom from the office, bathroom, cafeteria or other frequently visited areas?

Accommodations might include:

  • Additional transition time
  • Elevator access
  • Accessible classroom locations
  • Permission to leave crowded hallways early
  • Rest breaks
  • Assistance carrying heavy books or supplies
  • Access to supportive seating when needed

A child’s needs may also change as they grow, so accommodations that worked last school year may need to be revisited.

Consider Bathroom Access and Gastrointestinal Symptoms

Gastrointestinal symptoms can also affect a student’s school day. GACI and some medications used in the treatment of ARHR2 may be associated with gastrointestinal issues, so parents may want to discuss this possibility with their child’s healthcare team and school.

Depending on the child’s needs, accommodations could include permission for frequent or extended bathroom breaks, unrestricted bathroom access when symptoms occur or seating that allows the student to leave the classroom discreetly.

Making teachers and appropriate school staff aware of these needs ahead of time can help prevent a student from having to repeatedly explain a medical issue when they urgently need to use the restroom.

Create a Clear Plan for Medications

Students with GACI, ARHR2 and related conditions may have medications or supplements that need to follow a specific schedule. Treatment for these conditions is highly individualized and should always be directed by the student’s healthcare providers.

Before school starts, families should find out exactly how their child’s school handles medications and what documentation is required.

It may be helpful to provide:

  • An up-to-date medication and supplement list
  • Exact administration instructions from the medical team
  • Information about medications that must be given during school hours
  • Medications prescribed for use as needed, such as pain relief
  • Emergency medications, if applicable
  • Relevant medication precautions
  • Contact information for parents and medical providers

Medication procedures can differ significantly between schools and countries. In some schools, a nurse may manage medications. In others, a teacher, administrative employee or other designated staff member may be involved, depending on local policy and what the staff member is authorized and willing to do.

If your child’s school does not have a dedicated school nurse, schedule a meeting with school management to discuss its specific medical protocols. Find out who is authorized to store and supervise medication, where medications will be kept and what formal arrangements must be put in place to ensure your child receives their medication safely during school hours.

For medications that are taken only when symptoms arise, make sure both the student and appropriate staff understand the process. For example, a child who has prescribed pain relief available at school may need to know where to go, whom to ask and what steps staff must follow before the medication can be given.

Families can also review Brighter Hope Foundation’s Treatment Options and FAQ and Glossary of Terms for additional information about GACI, ARHR2, ENPP1 Deficiency and ABCC6 Deficiency.

Identify the Right Medical Contact at School

When a school has a dedicated nurse, that person can be an important connection between the student’s healthcare needs and everyday school life. However, not every school or country has school nurses, so families may need to identify another appropriate member of staff who can serve as their main contact for medical needs.

This may be a teacher, principal, school administrator, secretary or another designated employee, depending on the school’s policies.

Before the year begins, consider arranging a conversation with the appropriate staff member to explain your child’s diagnosis and, more importantly, what the condition looks like for your child.

Because many school staff members may never have encountered GACI, ARHR2, ENPP1 Deficiency or ABCC6 Deficiency before, providing a short written overview can be helpful.

Consider sharing:

  • Your child’s diagnosis
  • Current medications
  • Typical symptoms
  • Signs that your child is experiencing pain or fatigue
  • Mobility limitations
  • Hearing needs
  • Gastrointestinal or bathroom-access needs
  • Activities that may require modification
  • What constitutes an emergency for your child
  • When a parent or caregiver should be contacted
  • Emergency contacts
  • Relevant instructions from your child’s healthcare providers

Updating this information whenever medications, symptoms or medical recommendations change can help keep everyone on the same page.

Help Teachers Understand the Child, Not Just the Diagnosis

A rare disease can be complicated, but teachers do not necessarily need an extensive medical explanation. They need to understand how the condition may affect the student sitting in their classroom.

A simple back-to-school conversation might explain that a student may tire more quickly, need medication during the day, require bathroom breaks, struggle to hear instructions in a noisy room, need additional time walking between classes or occasionally miss school for specialist appointments.

It is also important to involve the student when age appropriate. As children get older, learning how to explain their needs, ask for a break, request medication or remind a teacher about an accommodation can be an important part of developing independence and self-advocacy.

A Back-to-School Checklist for Families

Before the first day, consider checking these items off your list:

  • Review the current IEP, 504 Plan or equivalent school support plan
  • Ask whether accommodations need to be updated
  • Identify the staff member responsible for coordinating medical needs
  • Provide current medical information and emergency contacts
  • Confirm medication policies, paperwork and supplies
  • Discuss PE and physical activity recommendations
  • Review mobility and accessibility throughout the school
  • Confirm hearing accommodations and assistive technology
  • Discuss bathroom access or gastrointestinal accommodations if needed
  • Tell key teachers what they need to know
  • Develop a plan for missed school due to appointments or illness
  • Check in again after the first few weeks to see what’s working

Starting the School Year with Confidence

Going back to school with a rare condition can require more planning, particularly when school medical resources and accommodation systems vary widely between countries and even between individual schools.

Every child affected by GACI, ARHR2, ENPP1 Deficiency or ABCC6 Deficiency has different abilities, symptoms and medical needs. A strong back-to-school plan begins by bringing together the people who know the child best: the family, healthcare team, appropriate school staff, teachers and the student themselves.

By communicating early, understanding the school’s procedures, putting appropriate accommodations in place and remaining flexible as needs change, families can help create a school environment where children can focus less on navigating barriers and more on learning, participating and being part of their school community.

For more educational information and resources, explore Brighter Hope Foundation’s resources for patients and families.

Medical note: This article is intended for general educational purposes and should not replace individualized recommendations from your child’s healthcare providers. School accommodation requirements, medication procedures and available medical support vary by school, region and country.

Step by Step: Why the 2026 Worldwide Walk Matters

On August 7, 2026, families, friends, and supporters around the world will walk 3 km together for one powerful reason: to support the Brighter Hope Foundation community. The Worldwide Walk is more than just a virtual event—it’s a celebration of strength, connection, and hope for families affected by Generalized Arterial Calcification of Infancy (GACI) and Autosomal Recessive Hypophosphatemic Rickets Type 2 (ARHR2).

This year’s walk carries a bold message: no one should have to face a rare diagnosis alone.

Why We Walk

To Raise Funds for our Financial Assistance Program

GACI and ARHR2 are ultra-rare conditions that currently have no cure. Your donations and fundraising help us to help families affected by ENPP1 deficiency or ABCC6 deficiency to attend the 2026 Patient & Family Conference, meet expert doctors and researchers, and connect with a community that truly understands their journey with GACI and ARHR2.

To Connect Families Around the Globe

For many families, a rare diagnosis comes with isolation. You may never have met another person with GACI or ARHR2 in your country. The Worldwide Walk bridges those distances. Whether you’re walking in your neighborhood, local park, or living room, you’re part of something bigger. You’re walking in solidarity with families from across the world who understand your journey.

To Spread Awareness

Rare diseases are often misunderstood or overlooked. By walking, sharing your story, and participating in local fundraising, you’re helping to shine a light on conditions that deserve attention. Increased awareness leads to faster diagnoses, better care, and a stronger, more informed community.

What to Expect

The 2026 Worldwide Walk is designed to be flexible and inclusive. There’s no set location—walk wherever and however you’d like.

  • Choose your own 3 km route on or around August 7th
  • Walk solo, with family, or as part of a team
  • Fundraise and share your page to help raise money for research and resources
  • Share your walk online to raise awareness in your own community

Did You Know?

Babies born with GACI face a survival rate of only 50%. For those who survive, many – specifically those with GACI caused by ENPP1 Deficiency – go on to develop ARHR2, a progressive condition that significantly affects bone development, growth, and mobility. Beyond these early challenges, children and adults living with ENPP1 or ABCC6 deficiency may also experience a wide range of complications, including seizures, strokes, chronic fatigue, persistent bone and joint pain, hearing loss, and dental issues.

Living with GACI or ARHR2 is not just a medical journey, it’s an emotional and financial struggle that families navigate every day. Supporting the Worldwide Walk helps expand awareness efforts that lead to earlier diagnoses and better care.

Your Support Matters.

Whether you’re a caregiver, a patient, a medical professional, or a friend of the cause, your steps make a difference.

“I’m walking 3km on August 7th, 2026, to raise awareness and support for those living with GACI and ARHR2 – two rare, lifelong conditions that deserve more attention, research, and resources.”

“We are fundraising so that babies born with GACI have a better chance and surviving patients can have a better quality of life.”

This spirit of unity is at the heart of Brighter Hope Foundation’s work. When you walk, you’re not just raising funds, you’re lifting up a global community that is often unseen.

Ready to Join Us?

Registration is now open for the 2026 Worldwide Walk.

Visit the official Worldwide Walk page to:

  • Register as a walker or team captain
  • Set up a fundraising page
  • Make a donation
  • Learn more about Brighter Hope Foundation

Let’s walk together toward a future of better research, stronger support, and greater awareness.

GACI Global Is Now Brighter Hope Foundation: A New Name, the Same Mission of Hope

For years, GACI Global has been a trusted source of support, education, and advocacy for families affected by Generalized Arterial Calcification of Infancy (GACI), ARHR2, ENPP1 Deficiency, and ABCC6 Deficiency. Today, the organization is proud to announce a new chapter: GACI Global has officially rebranded as Brighter Hope Foundation.

While the name has changed, the mission remains the same: connecting families, advancing awareness, supporting research, and creating hope for those impacted by ultra-rare genetic diseases.

Why the Organization Rebranded

The transition from GACI Global to Brighter Hope Foundation reflects the evolution of the organization and the growing community it serves. Over the years, the foundation’s reach has expanded beyond GACI awareness alone to include broader education, support, and advocacy for families affected by related rare diseases, including ENPP1 Deficiency and ABCC6 Deficiency.

The new name, “Brighter Hope Foundation,” better represents:

  • Hope for newly diagnosed families
  • Hope through medical research and treatment advancements
  • Hope through community connection and education
  • Hope for a brighter future for children and adults living with rare genetic conditions

The rebrand also creates a more inclusive identity that reflects the resilience of patients, caregivers, researchers, and supporters around the world.

Continuing the Mission to Support Families Affected by GACI and Rare Diseases

Brighter Hope Foundation continues to focus on improving the lives of individuals and families affected by:

The organization provides educational resources, patient support, webinars, conferences, fundraising initiatives, and community connections for families navigating these complex diagnoses.

Families affected by rare diseases often face challenges including delayed diagnosis, limited treatment options, and difficulty finding knowledgeable medical providers. Brighter Hope Foundation works to bridge those gaps by helping families connect with medical experts, research opportunities, and others who understand their journey.

Supporting Rare Disease Research and Awareness

Research remains a central focus of Brighter Hope Foundation’s work. Because GACI and related disorders are ultra-rare, awareness and funding are essential to improving diagnosis, treatment options, and long-term outcomes.

According to the organization, GACI affects approximately 1 in 64,000 pregnancies, and survival rates for infants remain a serious concern, especially during the first months of life.

Through fundraising campaigns, global awareness initiatives, patient conferences, and partnerships with researchers and medical professionals, Brighter Hope Foundation continues to advocate for advancements that could change the future for affected families.

A Global Community Built on Connection

One of the most important parts of the organization’s mission is helping families feel less alone. A diagnosis of GACI or ARHR2 can be overwhelming, especially because many healthcare providers may never encounter these conditions during their careers.

Brighter Hope Foundation creates opportunities for connection through:

These connections provide emotional support while also helping families better understand treatment options, research developments, and daily life with rare diseases.

What This Means for Supporters and Families

Although the organization now operates as Brighter Hope Foundation, supporters can expect the same dedication, compassion, and advocacy that defined GACI Global for years.

The rebrand represents growth, momentum, and a renewed commitment to:

  • Raising awareness of rare genetic diseases
  • Supporting families worldwide
  • Funding research efforts
  • Expanding educational resources
  • Building a stronger global community

The foundation’s new identity reflects a future centered on possibility, progress, and hope.

Learn More About Brighter Hope Foundation

To learn more about the organization, upcoming events, educational resources, and ways to support the mission, visit Brighter Hope Foundation.

Whether you are a patient, caregiver, medical professional, donor, or advocate, Brighter Hope Foundation continues to work toward a brighter future for families affected by GACI, ARHR2, ENPP1 Deficiency, ABCC6 Deficiency, and related rare diseases.

Living With Chronic Pain and Fatigue in GACI, ARHR2 and Related Conditions

woman-sitting-on-couch-with-hands-on-knee- gaci pain and fatigue

Chronic pain and fatigue can be a major part of life for people living with GACI, ARHR2, ENPP1 Deficiency, ABCC6 Deficiency, and related conditions. These symptoms may be linked to calcification, complications affecting soft-tissues, bones and joints,  mobility challenges, and the long-term burden of managing a progressive rare disease. While each person’s experience is different, understanding why these symptoms happen and knowing what support is available can help patients and families feel more prepared and less alone. Brighter Hope Foundation provides education, community support, and resources for families affected by ENPP1 and ABCC6-related conditions.

How GACI and related conditions can cause chronic pain and fatigue

GACI and related conditions do not affect only one body system. ENPP1 Deficiency can present in infancy as GACI Type 1, and many patients later develop ARHR2. ABCC6 Deficiency can present as GACI Type 2 in infancy.  Across the disease spectrum, patients may experience arterial calcification, bone and skeletal complications, hearing issues, reduced mobility, pain, and fatigue. Fatigue can be a feature of GACI, whether caused by ENPP1 Deficiency or ABCC6 Deficiency, and is often related to the impact of the condition on the cardiovascular system and overall health.,  ARHR2 is associated with severe bone pain, fractures, skeletal deformities, and fatigue.

Pain may happen for different reasons depending on the diagnosis, age, and stage of disease. Some people experience bone pain related to rickets or osteomalacia. Others may deal with joint pain, calcification in tissues, stiffness, or pain linked to altered gait, bone deformities, or reduced mobility. Fatigue can also build over time due to chronic pain, physical strain, poor sleep, frequent medical appointments, and the emotional stress of living with a lifelong rare disease. Brighter Hope Foundation’s recent educational article on living with ENPP1 Deficiency notes that around 85% of patients experience issues related to bone or joint pain, fatigue, mobility issues, and calcification of arteries, organs, or joints.

What daily life may be like

Living with chronic pain and fatigue often means adjusting everyday routines. A child may have trouble keeping up with peers during active play, sports, or long school days. A teen may struggle with discomfort, limited stamina, or frustration when symptoms are not visible to others. Adults may face persistent pain, reduced endurance, and the challenge of balancing work, family life, and medical care. Brighter Hope Foundation’s adult leaflet describes ENPP1 Deficiency and ABCC6 Deficiency as lifelong progressive diseases that require ongoing monitoring and supportive care.

For many families, daily life includes: 

  • pacing activities
  • planning around appointments
  • building in extra rest
  • watching for symptom changes
  • explaining symptoms to schools, employers, or caregivers 

Some days may feel manageable, while others may require more support. That is one reason patient education and community connection matter so much. Brighter Hope Foundation’s mission is centered on connecting affected families to each other and to the medical community.

Treatment and symptom management options

There is currently no known cure for GACI, ARHR2, ENPP1 Deficiency, or ABCC6 Deficiency, but symptom management and supportive care can play an important role in quality of life. Brighter Hope Foundation’s  treatment information explains that care may include medical treatment, ongoing monitoring, supplements, and procedures, depending on the patient’s diagnosis and needs.

Because chronic pain and fatigue can have several causes, treatment is usually individualized. Care may involve specialists in cardiology, endocrinology, nephrology, orthopedics, genetics, metabolic bone disease, audiology, and physical therapy, depending on symptoms and complications. Ongoing monitoring is important because these conditions can affect multiple parts of the body over time.

Supportive strategies may also help with day-to-day symptom management. Depending on a patient’s medical needs, this may include:

  • pacing activities and rest
  • mobility support or physical therapy
  • monitoring bone health
  • managing pain with guidance from the care team
  • adapting school, work, or home routines
  • staying connected to specialists familiar with ENPP1 and ABCC6-related disease

Low-impact movement may be helpful for some patients. Brighter Hope Foundation’s ARHR2 information notes that activities such as swimming, walking, pilates, and aqua aerobics may be beneficial for some individuals, though any exercise plan should be discussed with the patient’s medical team first.

Resources available through Brighter Hope Foundation

For families living with chronic pain and fatigue, trusted information can make a real difference. Brighter Hope Foundation offers a wide range of resources for patients, caregivers, and clinicians, including treatment information, testing guidance, fact sheets, and webinars. The organization also offers a private patient and family support group for those directly affected.

These resources can help families:

  • better understand symptoms and disease progression
  • prepare for appointments
  • learn what monitoring may be needed
  • connect with others who understand the journey
  • stay informed about research and clinical trials

Brighter Hope Foundation also provides patient stories, videos and webinars, newsletters, and educational materials reviewed by its Medical Advisory Board, helping families access information that is both compassionate and medically grounded.

FAQs About Chronic Pain and Fatigue in GACI

Can GACI cause chronic pain and fatigue?

GACI associated with ENPP1 or ABCC6 deficiency is not typically characterised by chronic pain, although fatigue may be experienced due to the cardiovascular and systemic effects of the condition. Pain is more commonly associated with ARHR2, which occurs in individuals with ENPP1 deficiency and is linked to bone, musculoskeletal, and soft‑tissue involvement.

Why are fatigue and pain common in ENPP1 Deficiency?

They may be related to bone and joint complications, rickets or osteomalacia, calcific enthesopathies, mobility limitations, ongoing disease burden, and the strain of managing a complex lifelong condition. Brighter Hope Foundation’s educational materials describe pain and fatigue as part of the symptom spectrum.

Is there a cure for chronic pain and fatigue in these conditions?

There is currently no known cure for the underlying conditions, but treatments, monitoring, and supportive care may help manage symptoms and improve quality of life.

Where can families find support?

Families can find support through Brighter Hope Foundation’s educational resources, fact sheets, webinars, testing and treatment information, patient registry information, and private patient and family support group.

Living with ARHR2: Understanding Daily Life with Autosomal Recessive Hypophosphatemic Rickets Type 2

Autosomal Recessive Hypophosphatemic Rickets Type 2 (ARHR2) is a rare genetic disorder that affects how the body regulates phosphate, a mineral essential for building strong bones and teeth. ARHR2 is associated with mutations in the ENPP1 gene, the same gene involved in Generalized Arterial Calcification of Infancy (GACI). While GACI often presents during infancy with vascular calcification, individuals with ENPP1 deficiency may later develop ARHR2, which primarily affects bone health.

Living with ARHR2 often involves managing chronic symptoms,navigating frequent medical appointments, coordinating care with multiple specialists, and adapting daily routines over time.. Although the condition presents challenges, early diagnosis, appropriate treatment, and ongoing support can help individuals maintain an active and fulfilling life.

At Brighter Hope Foundation, we work to provide families and patients with reliable information, resources, and community connections for those living with GACI, ENPP1 deficiency, ARHR2, and related conditions.

What Is ARHR2?

ARHR2 is a form of hypophosphatemic rickets, meaning the body loses too much phosphate through the kidneys. Phosphate is necessary for proper bone mineralization, so low levels can lead to weakened bones, skeletal deformities, and delayed growth.

For individuals with ENPP1 deficiency, ARHR2 may develop later in childhood or adolescence, regardless of whether symptoms of GACI were present earlier in life.

Symptoms can vary but may include:

  • Bone pain or tenderness
  • Delayed growth or short stature
  • Bowing of the legs, ‘knock-knees’, or other skeletal abnormalities
  • Muscle weakness or fatigue
  • Hearing loss due to the abnormal mineralization in the bones of the inner ear
  • Dental problems related to weakened tooth enamel

Because ARHR2 is part of the broader spectrum of ENPP1 deficiency, individuals may experience symptoms at different stages of life. Consistent medical monitoring is an important part of long-term care.

Daily Life and Common Challenges

Living with ARHR2 often requires ongoing management and adjustments to daily routines. Many individuals and families work closely with healthcare providers to monitor phosphate levels, bone development, and overall health.

Common aspects of living with ARHR2 may include:

  • Medication and supplementation to help regulate phosphate levels and support bone health
  • Regular blood tests to monitor phosphate, calcium, and other metabolic markers
  • Orthopedic evaluations to monitor skeletal growth and bone structure
  • Physical therapy or supportive care to help manage pain and mobility challenges
  • Hearing evaluations, as progressive or early‑onset hearing loss has been reported in some individuals with ARHR2 / ENPP1 deficiency
  • Nephrology evaluations, as phosphate and vitamin D can sometimes cause nephrocalcinosis in patients with ARHR2 / ENPP1 deficiency
  • Dental monitoring, as enamel defects and other dental concerns can occur

Children with ARHR2 may also need additional monitoring during periods of rapid growth, when bone development changes quickly.

The Importance of Ongoing Care and Monitoring

Because ARHR2 is a rare metabolic bone disorder, care often involves collaboration among multiple medical specialists. This may include:

  • Endocrinologists who specialize in metabolic bone diseases
  • Nephrologists, since phosphate balance is regulated by the kidneys
  • Orthopedic specialists who monitor bone development and skeletal health
  • Dentist 
  • Audiologist
  • Cardiologist since some adult patients with ARHR2 have ongoing cardiac care concerns

Regular imaging, lab work, and clinical evaluations help ensure treatment plans remain effective as individuals grow and their needs change.

Early diagnosis and careful monitoring can play a significant role in improving quality of life and preventing complications.

The Emotional Impact on Individuals and Families

Living with a rare disease like ARHR2 can affect more than just physical health. Families often face uncertainty, difficulty finding knowledgeable specialists, and the emotional strain that can come with managing a chronic condition.

Individuals and families may experience:

  • Frustration when symptoms affect mobility or daily activities
  • Anxiety around medical appointments, tests, or treatments
  • Feelings of isolation due to the rarity of the condition
  • The challenge of explaining the condition to schools, friends, or community members

Connecting with other families who understand these experiences can be incredibly valuable. Support networks like Brighter Hope Foundation  help provide reassurance, shared knowledge, and a sense of community. Check out our blog:Living with a Rare Disease and the Strain on Mental Health to learn more.

Finding Support and Reliable Information

Because ARHR2 is closely connected to ENPP1 deficiency and GACI, organizations focused on these conditions play an important role in supporting affected families.

Brighter Hope Foundation provides:

  • Educational resources about GACI, ENPP1 deficiency, ARHR2, and related conditions
  • Informational videos from medical experts
  • Community connections for families navigating these rare diseases
  • Updates on ongoing research and emerging therapies

Our goal is to help individuals and families better understand these conditions and ensure they have access to the information and support they need.

Learn More and Connect with the Community

Living with ARHR2 can present challenges, but individuals and families do not have to navigate the journey alone.

We encourage you to explore Brighter Hope Foundation’s educational resources,informational videos, and community support programs to learn more about ARHR2, ENPP1 deficiency, and related conditions.If your family has been affected by ARHR2, Brighter Hope Foundation is here to help you find information, connect with other families, and navigate the challenges of this rare disease. Contact us today.

Living with GACI: Understanding the Journey and Finding Support

Living with GACI (Generalized Arterial Calcification of Infancy) means navigating a rare and complex genetic condition that affects the body in profound ways. GACI is characterized by abnormal calcification in the arteries, which can lead to serious cardiovascular complications early in life. While the diagnosis can feel overwhelming, families today have access to growing medical knowledge, specialized care, and a supportive global community.

At Brighter Hope Foundation, our mission is to provide education, advocacy, and connection for individuals and families impacted by GACI and related disorders.

What Is GACI?

Generalized Arterial Calcification of Infancy (GACI) is a rare inherited condition most commonly caused by mutations in the ENPP1 gene and less commonly by mutations in the ABCC6 gene. Mutations in ENPP1 disrupt the body’s ability to regulate pyrophosphate, a molecule that normally prevents calcium from depositing in soft tissues such as blood vessels. Many individuals with ENPP1 deficiency who survive infancy later develop Autosomal Recessive Hypophosphatemic Rickets Type 2 (ARHR2), a condition that affects phosphate metabolism and bone health.

 Infants diagnosed with GACI may develop:

  • Calcium deposits in medium and large arteries
  • Arterial narrowing (stenosis)
  • High blood pressure
  • Heart complications
  • Potential organ damage due to restricted blood flow
  • Feeding difficulties and slow growth
  • Irritability and breathing difficulties
  • Joint calcification which can cause pain and reduced mobility
  • Hearing loss

Families can find more detailed information about the condition in the Medical Information section of the Brighter Hope Foundation website.

Daily Life and Ongoing Monitoring

Living with GACI often requires close medical oversight, especially in infancy and early childhood. Because GACI can affect multiple organ systems, care may involve:

  • Pediatric cardiologists
  • Nephrologists
  • Endocrinologists
  • Genetic specialists
  • Audiologists

Routine monitoring may include echocardiograms, blood pressure checks, laboratory testing, and imaging studies to assess the progression of calcification and vascular narrowing.

Some individuals who survive infancy may later develop complications such as ARHR2, which affects phosphate metabolism and bone health. Understanding this progression is critical, and families are encouraged to review the Treatment Options section of the website to better understand available therapies and supportive interventions.

The Emotional Impact on Families

A diagnosis of GACI can change a family’s life overnight. Many parents have never heard of the condition before their child is diagnosed. They may experience shock, fear, and uncertainty about survival rates, long-term outcomes, and quality of life. Because GACI is so rare, families often struggle to find physicians with experience managing the condition.

Beyond the medical complexity, there is also emotional strain:

  • Anxiety around medical appointments
  • Financial stress related to specialized care
  • Isolation due to the rarity of the condition
  • Grief associated with uncertain prognosis

Connecting with other families who understand the journey can be transformative. Brighter Hope Foundation offers educational materials, awareness initiatives, and opportunities for connection through community resources and events.

Advances in Research and Hope for the Future

Research into ENPP1 deficiency, ABCC6 deficiency, and related calcification disorders continues to evolve. Scientists are studying how pyrophosphate pathways regulate calcium buildup in arteries and how targeted therapies may slow or prevent arterial damage.

Brighter Hope Foundation works closely with itsMedical Advisory Board to stay informed about emerging treatments and to ensure families have access to accurate, up-to-date information. Continued advocacy and funding are essential to improving outcomes and long-term survival.

As awareness increases, so does hope. Earlier diagnosis, improved treatment strategies, and coordinated multidisciplinary care are making a meaningful difference for individuals living with GACI.

Finding Strength Through Community

Living with GACI is not a journey any family should face alone. Whether you are newly diagnosed, managing long-term complications, or supporting a loved one, education and connection matter.

Brighter Hope Foundation provides:

If you or a loved one has been affected by Generalized Arterial Calcification of Infancy, we encourage you to explore the educational resources, learn about ongoing research efforts, and connect with the broader GACI community.

 If your family has been affected by GACI, Brighter Hope Foundation is here to help you find information, connect with other families, and navigate the challenges of this rare disease.

Living with ABCC6 Deficiency

Living with ABCC6 Deficiency can involve a wide range of experiences, from serious medical challenges in infancy to slowly developing symptoms later in life. This rare genetic condition affects the body’s ability to regulate mineralization, increasing the risk of calcium buildup in arteries and soft tissues. Because symptoms can vary significantly and evolve over time, individuals and families often face uncertainty around diagnosis, progression, and long-term care.

This blog explores how ABCC6 Deficiency may affect daily life, why ongoing monitoring is essential, and the emotional realities many families face. It also highlights how Brighter Hope Foundation supports individuals and families affected by ABCC6 Deficiency, GACI, ENPP1 Deficiency, and ARHR2 through education,resources, and community connection.

Understanding ABCC6 Deficiency

ABCC6 Deficiency is caused by pathogenic variants in the ABCC6 gene, which plays an important role in maintaining levels of pyrophosphate (PPi). PPi helps prevent abnormal calcium deposition in soft tissues and blood vessels. When ABCC6 function is impaired, PPi levels are reduced, increasing the risk of ectopic calcification.

ABCC6 Deficiency can present differently depending on age and disease progression, including:

  • Generalized Arterial Calcification of Infancy (GACI Type 2)
     In some infants, ABCC6 Deficiency leads to early calcification and narrowing of arteries, which can severely affect blood flow and organ function.
  • Pseudoxanthoma Elasticum (PXE)
     In later childhood or adulthood, ABCC6 Deficiency is most commonly associated with PXE, a progressive condition affecting the skin, eyes, and cardiovascular system.

Because ABCC6 Deficiency exists on a spectrum, symptoms and severity vary widely. Learning how the condition may change over time helps families prepare for proactive care.

Daily Life and Common Challenges

Living with ABCC6 Deficiency often requires adapting to symptoms that may develop gradually or change over time. Daily challenges depend on how the condition presents and which systems are affected.

Common experiences may include:

  • Early-life medical complexity
     Infants with GACI Type 2 may require intensive monitoring and specialized care due to arterial calcification and cardiovascular and cerebrovascular risks.
  • Skin changes
     Individuals with PXE may notice thickened, loose, or dimpled skin, particularly on the neck or in flexural areas.
  • Vision monitoring
     Eye findings such as angioid streaks may not cause immediate vision loss but require regular ophthalmologic exams to detect changes early.
  • Cardiovascular symptoms
     Some individuals experience heart failure, reduced circulation, leg pain with walking, or increased risk of peripheral artery disease.
  • Cerebrovascular symptoms
    Some individuals experience strokes and seizures.
  • Physical fatigue or discomfort
     Reduced stamina or chronic discomfort can affect daily routines and activity levels.

The unpredictable nature of ABCC6 Deficiency can make daily planning difficult, but consistent care and awareness help many individuals maintain an active and meaningful quality of life.

The Importance of Ongoing Care and Monitoring

There is currently no cure for ABCC6 Deficiency, making early diagnosis and lifelong monitoring especially important. Ongoing care focuses on managing symptoms, preventing complications, and preserving function.

Care typically involves:

  • Multidisciplinary medical teams
     Specialists may include cardiology, ophthalmology, dermatology, genetics, nephrology, and primary care.
  • Routine cardiovascular assessments
     Monitoring arterial health helps identify changes early and reduce long-term risks.
  • Regular eye exams
     Early detection of retinal changes supports vision preservation.
  • Individualized long-term care planning
     Treatment and monitoring plans evolve as symptoms change over time.

Even for individuals diagnosed later in life, establishing a structured care plan can significantly improve long-term outcomes.

The Emotional Impact on Individuals and Families

The emotional burden of ABCC6 Deficiency is often as significant as the physical challenges. Families may experience fear, stress, or grief at diagnosis, especially when the condition presents in infancy. Individuals diagnosed later may struggle with uncertainty about progression and future health.

Emotional challenges may include:

  • Anxiety around long-term outcomes
     The variable nature of ABCC6 Deficiency can make it difficult to predict what lies ahead.
  • Feelings of isolation
     Rare conditions are often unfamiliar to others, including some healthcare providers.
  • Concerns about appearance or physical ability
     Skin changes, vision monitoring, or mobility concerns can affect confidence and mental well-being.

Connecting with others who understand the journey can be incredibly powerful. Shared experiences help individuals and families feel supported, validated, and less alone.

How Brighter Hope Foundation Supports Families Living with ABCC6 Deficiency

At Brighter Hope Foundation, we are dedicated to supporting individuals and families affected by ABCC6 Deficiency and related conditions, including GACI, ENPP1 Deficiency, and ARHR2. We recognize the shared biological pathways and overlapping challenges these disorders present.

Our support includes:

Living with ABCC6 Deficiency can bring lifelong challenges, but education, proactive monitoring, and strong support systems make a meaningful difference. As awareness and research continue to grow, so does hope for improved understanding and care.

We invite you to explore our informational videos and community resources linked above, which provide trusted education, shared experiences, and ongoing support for individuals and families affected by GACI, ABCC6 Deficiency and related conditions.

Living with ENPP1 Deficiency

Living with ENPP1 Deficiency presents a unique set of challenges that affect the body in complex and often life-altering ways. Because this rare genetic condition can lead to vascular calcification, bone abnormalities, and chronic pain, individuals and families may face uncertainty and fear, especially around diagnosis and long-term management. Yet with early intervention, continued monitoring, and a strong support network, many people living with ENPP1 Deficiency lead fulfilling and active lives.

This blog explores what ENPP1 Deficiency means, how it impacts daily life, and the practical and emotional realities families often navigate. It also highlights how Brighter Hope Foundation helps connect, educate, and empower those living with ENPP1 Deficiency, GACI, and ARHR2.

Understanding ENPP1 Deficiency

ENPP1 Deficiency is a genetic disorder caused by variants in the ENPP1 gene. This gene plays a vital role in regulating pyrophosphate (PPi), a molecule responsible for preventing abnormal calcification in the body. When ENPP1 is deficient, calcium can deposit where it should not, such as in arteries and joints, creating the potential for significant complications.

Some individuals present with features similar to Generalized Arterial Calcification of Infancy (GACI Type 2), including early vascular calcification and risk of cardiac complications. Others later develop Autosomal Recessive Hypophosphatemic Rickets Type 2 (ARHR2), which often involves low phosphate levels, bone pain, fractures, and mobility concerns. Most patients who survive GACI Type 1 will go on to develop ARHR2.

Because symptoms vary widely, each individual’s experience is unique, making education, awareness, and individualized care essential.

Daily Life and Common Challenges

Living with ENPP1 Deficiency often brings a mix of visible and invisible challenges. These may include:

  • Bone Pain and Fatigue
     Children and adults may experience chronic discomfort that affects daily activities, movement, and quality of life.
  • Skeletal or Growth Differences
     Bowed legs, delayed walking, short stature, or recurring fractures may occur.
  • Vascular Concerns
     Some individuals require ongoing cardiology monitoring due to risks associated with arterial calcification.
  • Emotional and Mental Stress
     Frequent appointments, complex treatment plans, and uncertainty about the future can place strain on both individuals and caregivers.
  • Financial and Logistical Burdens
     Traveling to specialists, coordinating multiple providers, and accessing long-term care can be overwhelming for families.

 Around 85% of patients experience issues related to bone or joint pain, fatigue, mobility issues, and calcification of arteries, organs, or joints. With the right support and care team, many families find ways to adapt, build resilience, and navigate daily life with greater confidence.

The Importance of Early Diagnosis and Multidisciplinary Care

Because ENPP1 Deficiency is a spectrum of disease that may include both  GACI and ARHR2, early identification can significantly improve long-term outcomes. Individuals may work with a team of specialists such as:

  • Cardiology
  • Nephrology
  • Endocrinology
  • Orthopedics
  • Genetics
  • Physical Therapy

A collaborative approach ensures consistent monitoring of bone health, cardiovascular function, growth, and overall development. Even those diagnosed later in life can benefit from interventions that improve mobility, reduce pain, and support daily functioning.

Family Experiences and Emotional Well-Being

The emotional impact of ENPP1 Deficiency is often significant. Families may face fear of complications, frustration around accessing specialized care, or stress related to ongoing medical demands. Children and adults with the condition may also experience anxiety tied to physical limitations or uncertainty about the future.

Connecting with others who understand the journey can be incredibly healing. Shared stories, peer support, and encouragement from the rare disease community help families feel seen, supported, and less alone.

How Brighter Hope Foundation Supports Families Living with ENPP1 Deficiency

Whether families receive a diagnosis in infancy, childhood, or adulthood, Brighter Hope Foundation is committed to guiding them every step of the way. Our support includes:

  • Educational Resources that explain symptoms, treatments, and long-term care.
  • Family Connections through support groups, online communities, and peer networks.
  • Advocacy and Awareness Efforts promoting research and improved clinical understanding.
  • Navigation Assistance to help families find specialists, reliable information, events and supportive services.

Our mission is to ensure that no one faces ENPP1 Deficiency alone. We provide the tools, knowledge, and community needed to make informed decisions and feel supported throughout every stage of the journey.

Explore More Support

To continue learning and connecting, we invite you to review our informational videos and community resources, designed to help you better understand ENPP1 Deficiency, GACI, ARHR2, and the support available to families worldwide. These tools offer education, guidance, and encouragement as you navigate each step of your journey.